Sante Capital Fund’s Johnson & Johnson JNJ Stock Holding History

Sante Capital Fund’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$2.18M	Buy	+13,319	New	+$2.25M	4.45%	2

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sante Capital Fund's JNJ Position: Q3 2022 in Review

Sante Capital Fund opened a new position in Johnson & Johnson (JNJ) in Q3 2022: 13,319 shares worth $2.18M. The stake represents 4.45% of the portfolio and ranks #2 among its holdings.

3,622 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.

Sante Capital Fund held 13,319 shares of Johnson & Johnson worth $2.18M as of Q3 2022.
Johnson & Johnson was a new Sante Capital Fund position in Q3 2022.
Johnson & Johnson made up 4.45% of Sante Capital Fund's portfolio in Q3 2022, its #2 holding.
3,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.

Based on Sante Capital Fund's 13F filing for Q3 2022, filed 14 Nov 2022.